Summary
Adam Smith is a PhD researcher at the University of Nottingham focused on uncovering novel therapeutic strategies for brain cancer, currently investigating anti-inflammatory drugs and bio-nanoantennae electrical stimulation in glioblastoma. With an MSc in Oncology and a BSc in Pharmaceutical Sciences, he brings 12 years of diverse experience spanning cancer biology, pharmacology, and hands-on lab techniques. His work bridges molecular mechanisms and translational drug development, aiming to move promising insights toward patient benefit. Outside the lab he has tutored biology and chemistry and balanced practical roles in hospitality and logistics, demonstrating strong communication and operational resilience. Based in Nottingham, he combines rigorous academic training with a pragmatic, multidisciplinary approach to tackling complex oncology problems. Notably, his project integrates electrical stimulation with pharmacologic modulation — an unconventional pairing that signals a willingness to explore disruptive therapeutic avenues.
12 years of coding experience
Oncology MSc, Oncology and Cancer Biology, Merit, Oncology MSc, Oncology and Cancer Biology, Merit at University of Nottingham